Why Gilead Stock Is a Good Buy for the Long Term
February 14, 2020 at 11:06 AM EST
Gilead stock is still recovering from the decline of its once-booming hepatitis C business - that's what happens when you cure most of your customers. But over the past year, with a new CEO, this biotech has taken steps that will return it to growth. Wall Street doesn't realize it yet, but GILD is a stock to buy... Tags: Gilead stock To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2020 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Why Gilead Stock Is a Good Buy for the Long Term appeared first on Money Morning - We Make Investing Profitable .